← Leaderboards
Venee N Tubman
Baylor College Of Medicine
$815,860
Attributed
$815,860
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $163.2K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$815,860 · 1
By mechanism
K23$815,860 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Elizabeth Chiao$12,842,422
- William Thomas Shearer$34,592,326
- Helen E Heslop$25,308,937
- Zhaoyong Hu$3,424,065
- Farook Jahoor$8,036,031
Others in their field
Other Emerging Leaders on “Abnormal Cell”
- Deborah Requesens · Coriell Institute For Medical Research$9,141,224
- Elizabeth Ann Sugar · Johns Hopkins University$6,288,276
- Graham Bench · Lawrence Livermore National Security, Llc$6,245,031
- Stephen Matthew Eacker · Phase Genomics, Inc.$5,675,858
- Xiaobo Mao · Johns Hopkins University$5,651,396
- Gareth John Morgan · Tezcat Laboratories Llc$5,575,548
Research focus
Abnormal CellAcuteAfricaAfrica South Of The SaharaAnxa5 GeneApoptosisBacteremiaB-Cell DevelopmentB Cell DifferentiationBcl2 GeneBiomarker DevelopmentB-LymphocytesB-Lymphocyte SubsetsCasp3 GeneCessation Of LifeChestChildChildhoodClinical PhenotypeCoculture TechniquesCohortCustomCytokine5 Year Old
Grant awards (5)
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease$163,172
K23 · FY2024 · HL · contact PI
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease$163,172
K23 · FY2023 · HL · contact PI
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease$163,172
K23 · FY2022 · HL · contact PI
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease$163,172
K23 · FY2021 · HL · contact PI
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease$163,172
K23 · FY2020 · HL · contact PI